Article Information
History
- September 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hannah W. Despres1,#,
- Margaret G. Mills2,#,
- David J. Shirley3,
- Madaline M. Schmidt1,
- Meei-Li Huang2,
- Keith R. Jerome2,4,
- Alexander L. Greninger2,4 and
- Emily A. Bruce1,*
- 1Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington VT, 05405, USA
- 2Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA 98195, USA
- 3Faraday, Inc. Data Science Department. Burlington VT, 05405, USA
- 4Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA 98109, USA
- ↵*Correspondence: Emily.bruce{at}med.uvm.edu (EAB)
↵# HWD and MGM contributed equally to this work.
Posted September 20, 2021.
Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants
